A scan can knock the breath out of you. You start treatment, hold onto hope, then hear that a tumor looks bigger. How could that possibly be good news?
When you experience pseudoprogression during immunotherapy, the first picture can look worse even when the treatment is beginning to succeed. This phenomenon is most frequently observed in patients navigating the complexities of metastatic disease or those managing solid tumors. If you are currently in treatment or monitoring your progress after a diagnosis, understanding this strange idea is essential for interpreting your scan results with confidence.
Key Takeaways
- Pseudoprogression occurs when tumors appear to grow on imaging due to an influx of immune cells and inflammation, rather than actual cancer growth.
- This phenomenon is rare, occurring in less than 10 percent of patients, meaning most scans indicating growth still reflect true disease progression.
- Immunotherapy functions by activating your immune system, which can cause a temporary “tumor flare” that looks like a worsening condition on early scans.
- Doctors distinguish between pseudoprogression and true progression by evaluating clinical symptoms, lab results, and comparing follow-up imaging rather than relying on a single scan.
- It is vital to communicate openly with your oncology team; do not assume a bad scan means treatment failure until you have discussed the full clinical context.
What this confusing word actually means
The term pseudoprogression immunotherapy sounds technical, but the core idea is simple. Because “pseudo” means false, pseudoprogression describes a situation of false worsening.
In clinical terms, this phenomenon is often linked to the use of immune checkpoint inhibitors, which are medications that wake up your immune system to fight cancer cells. This is particularly well-documented in cases of melanoma. When your immune cells receive that signal and rush into a tumor site, they can cause the area to swell. On medical imaging, this swelling may look like the tumor is growing or that new spots are appearing. Some clinicians refer to this specific inflammatory response as a tumor flare.
That appearance does not always mean the cancer is winning. It can mean your body has started a fight that the scan catches at a messy moment.
Think of a room under repair. Midway through the job, the room can look worse than it did before the work began. Dust is everywhere and tools cover the floor, but the mess does not mean the renovation failed.
A patient-friendly explanation from why tumor growth may be a good sign says the same thing in more clinical terms. Early growth on imaging can come from immune activity rather than the tumor taking over.
Still, the hard truth is that pseudoprogression is real, but uncommon. An ASCO report on pseudoprogression rates found an overall occurrence rate of under 10 percent. Most scans that look worse reflect true disease progression, which is why doctors always take these results seriously.
A bigger scan does not always mean treatment failed, but it also should never be ignored.
That tension is what makes scan day so heavy. Hope and fear can sit in the same chair when you are waiting for clarity.
Why a tumor can look bigger at first
Immunotherapy functions differently than standard chemotherapy. While chemotherapy attacks cancer cells directly, immunotherapy works by training your immune system to recognize and target them. This often involves PD-1 or PD-L1 inhibitors, which release the brakes on your immune response.
This difference is critical for understanding imaging results. When treatment begins, your body may experience significant immune cell infiltration, where active CD8+ T cells flood the tumor site. As these immune cells, along with fluid and inflammation, accumulate, the overall tumor size can appear to increase on a scan. Essentially, the imaging is capturing a chaotic traffic jam of immune activity before the cleanup phase becomes visible.
This phenomenon is known as pseudoprogression. It is important to distinguish this from hyperprogression, a rare but different scenario where a tumor begins to grow rapidly shortly after starting treatment. Because these situations look so different from true disease progression, doctors rely on more than just the first scan to interpret how you are responding.
A detailed NIH review on telling true progression apart explains how difficult this analysis can be, even for experienced oncology teams. Because imaging does not provide the whole story, your physical symptoms are equally important. If you feel stronger, breathe easier, or have less pain, those signs may suggest that the treatment is effective despite what a scan shows. Conversely, if your symptoms worsen significantly, the concern for true disease progression increases.
Doctors also work to rule out other factors. A new spot on a scan might result from an infection or localized inflammation rather than cancer growth. That is why they never rely on a single scan to make a definitive diagnosis. Cancer care requires you to live with uncertainty, and this is one of those moments. The first image may show a storm, but it does not always tell you where the wind will settle.
How doctors decide whether treatment is working
Doctors do not guess. They gather clues. They perform a clinical assessment that combines your scan results, current symptoms, lab work, and the speed at which changes occur. They also ask a practical question: Is it safe to wait for another scan, or does this situation require an immediate change in strategy?
To navigate this, clinicians use standardized tools. While traditional RECIST parameters are the gold standard for measuring tumor burden, they often struggle to capture the nuances of immunotherapy. This is why many teams now use iRECIST, a framework specifically designed to help identify the difference between pseudoprogression and true disease progression.
This comparison helps visualize the process:
| What doctors look at | Pseudoprogression | True disease progression |
|---|---|---|
| Scan appearance | Tumor looks larger or new lesions appear early | Consistent growth patterns in tumor burden |
| How you feel | Often stable or showing signs of improvement | Often worsening, though not always |
| What happens next | Later scans may show shrinkage | Later scans show continued growth |
| Treatment plan | Potential for treatment continuation | Doctors may change to a new therapy |
The table is simple, but real life is not. Some people feel stable even when cancer grows. Some people feel awful from side effects even when treatment works. That is why your oncology team performs a comprehensive radiological assessment to see the full picture.
If you are stable, your doctor may suggest treatment continuation and order another scan a few weeks later. If the cancer threatens an organ, causes major symptoms, or grows rapidly, they may switch plans sooner. Sometimes they use a biopsy to gain clarity. Throughout this, the team remains focused on your overall survival, balancing the risks of staying the course against the need for a new approach.
This part matters: do not decide on your own that a bad-looking scan is either a disaster or good news. Both mistakes can hurt. Ask your team what they think, why they think it, and what they need to see next.
A few questions can open the door:
- What makes you think this could be pseudoprogression?
- Do my symptoms align with what the scan shows?
- When will the next scan provide a clearer answer?
Plain answers matter. You have every right to ask for them.
Living through the wait without losing your footing
The medical part of pseudoprogression is hard. The emotional part can feel harder.
You hear “possible growth,” and your mind races ahead. You picture treatment failure. You picture lost time. You picture the life you were trying to hold together slipping again. That reaction is human. It is not weakness.
Cancer teaches strange lessons. Sometimes courage looks loud. Sometimes it looks like showing up for one more appointment, one more infusion, or one more follow-up scan.
If you have reached remission before, you know this too well. A single phone call can wake old fear in seconds. The body remembers. The heart remembers. That happens after cancer and after any life-threatening disease that has already changed how you measure safety.
So what helps while you wait?
It helps to understand the clinical challenges inherent in this phase. While imaging often shows growth, doctors are increasingly looking toward emerging tools like biomarkers or a liquid biopsy to provide more clarity. These methods may eventually offer a way to track progress without the need for a traditional, invasive tissue biopsy to confirm whether the tumor is truly growing or simply responding to therapy.
Keep your questions in one place. Bring someone with you if you can. Ask your doctor to explain the scan in everyday words. If a term sounds confusing, stop and ask again. You are not slowing things down. You are caring for yourself.
Emotional support matters here, not as a side note, but as part of getting through treatment. On days when the fear feels louder than the facts, reading something gentle can steady you. Pieces like finding peace through a new outlook on cancer can help soften the mental spiral that often follows uncertain results.
You can also turn to compassionatevoices.org for educational materials and support around cancer and other life-threatening diseases. Sometimes the best next step is not a new answer. Sometimes it is a clearer breath, a better question, and a reminder that you do not have to carry the fear alone.
The waiting is still hard. But hard does not mean hopeless.
Frequently Asked Questions
If my scan shows growth, does that mean my immunotherapy has failed?
Not necessarily. While growth often suggests that a tumor is getting larger, it can also be a sign of a robust immune response where white blood cells have flooded the area to fight the cancer. Your doctor will need to look at your symptoms and follow-up scans to determine if this is temporary inflammation or true progression.
How long does pseudoprogression typically last?
There is no single timeline for this phenomenon, as every patient’s immune system reacts differently to treatment. Clinicians usually schedule follow-up imaging in a few weeks to monitor the site and see if the “flare” begins to recede, which confirms the treatment is working.
Can I feel the difference between pseudoprogression and real tumor growth?
Sometimes, but not always. If your physical symptoms—such as breathing, pain levels, or energy—are improving despite a scan that looks “worse,” your doctor may take that as a positive sign. However, because these symptoms can be subjective, imaging and blood work remain the most reliable tools for your medical team.
Why do doctors use iRECIST instead of traditional scans?
Standard measurements like RECIST are designed to track shrinkage in chemotherapy, but they often struggle to account for the immune-driven swelling seen in immunotherapy. The iRECIST framework provides a more nuanced way for doctors to differentiate between an initial inflammatory response and a treatment that is actually not working.
What to hold onto after the scan
A scan that shows increased tumor growth after treatment does not always mean your therapy has failed. In many cases, it simply means your immune system has arrived at the site, but the scan has not yet caught up to show the progress.
That is the heart of pseudoprogression. It is an uncommon but real phenomenon that is impossible to confirm from one image alone. Because it is difficult to distinguish pseudoprogression from true disease progression based on a single scan, your next best step is not to guess. Instead, stay in close contact with your oncology team. Any change in your therapeutic intervention should be a joint decision made only after discussing the follow-up evidence.
Some of the hardest moments in cancer care come wrapped in uncertainty. Hope does not ask you to deny that reality. It simply asks you to leave room for the possibility that the first look is not the final answer when navigating your journey with immunotherapy.
